The Know AML website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and Know AML cannot guarantee the accuracy of translated content. Know AML and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
Anna Mamwell
November 9, 2020
During Blood Cancer Awareness Month, Know AML spoke to Anna Mamwell, a patient in remission. We asked, What monitoring requirements did you find to be the most challenging (in terms of logistics, frequency, burden of administration, etc.)? In this video, Anna details that her monitoring requirements now consist of blood tests only. This does not seem like a 'burden,' because it is a way of keeping in touch with the clinical team and keeping safe.
You can find additional patient journey resources via our interactive graphic page.
To what extent do you agree with the following statements?
Please rate between 1 and 5, with 1 being 'strongly disagree' and 5 being 'strongly agree'.